Cargando…
Low mean HbA1c does not increase all-cause and cardiovascular mortality in patients with diabetes: Effect-modifications by anemia and chronic kidney disease stages
BACKGROUND: Previous studies reported that low levels of glycated hemoglobin A1c (HbA1c) were associated with increased mortality. We investigated rates and risks of all-cause and cardiovascular mortality in association with mean HbA1c levels with stratification of anemia and chronic kidney disease...
Autores principales: | Ooi, Seng-Wei, Yeh, Shu-Tin, Chang, Ya-Hui, Li, Chung-Yi, Chen, Hua-Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371313/ https://www.ncbi.nlm.nih.gov/pubmed/35951657 http://dx.doi.org/10.1371/journal.pone.0272137 |
Ejemplares similares
-
Different levels of hypoglycemia in patients with type 2 diabetes, their achieved mean HbA1c vs. all-cause and cardiovascular mortality
por: Ooi, Seng-Wei, et al.
Publicado: (2023) -
Estimation of mean erythrocyte age using HbA1c or HbA1c/glycated albumin for evaluation of anemia severity
por: Koga, Masafumi, et al.
Publicado: (2023) -
Point-of-Care Measurements of HbA(1c): Simplicity Does Not Mean Laxity With Controls
por: Leca, Viviane, et al.
Publicado: (2012) -
The relationship of low-density lipoprotein cholesterol and all-cause or cardiovascular mortality in patients with type 2 diabetes: a retrospective study
por: Chang, Chin-Huan, et al.
Publicado: (2023) -
Glycated Haemoglobin (HbA1c) Variations in Nondiabetics With Nutritional Anemia
por: Pilla, Rakesh, et al.
Publicado: (2020)